Understanding Intestinal Damage Markers After Abdominal Radiation
Part of Digestive system clinical trials.
This study examines blood and tissue markers that show how radiation therapy affects the intestines during cancer treatment. The goal is to better understand and predict intestinal damage so doctors can prevent or treat it more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You received or are receiving abdominal radiation therapy with a dose of at least 45 Gray (a standard radiation measurement)
- You are 18 years old or older
- You are healthy enough to participate (Karnofsky score above 60, meaning you can do most normal activities)
- Your doctors expect you to live at least 6 more months
- You have not had abdominal radiation therapy before this current treatment
- You are able and willing to provide blood and tissue samples
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if local steroids can help heal bowel damage caused by radiation therapy for cancer. It may reduce pain, bleeding, and urgency, and improve quality of life.
This study explores why some patients develop bladder problems after receiving high-dose radiation to the abdomen. Researchers will collect samples to identify warning signs (biomarkers) that might predict or detect these changes early.
This study looks at how a natural gut hormone called GLP-2 changes in your blood after radiation treatment for cancer in the belly or pelvic area, and whether it relates to gut irritation (radiation enteritis). It may help doctors understand and better manage radiation side effects.
This study looks at different types of radiation rectal injury to understand how they affect recovery. It may help you if you have been diagnosed with this condition and are not currently undergoing cancer treatment.
This trial tests whether a special type of stem cells (from umbilical cord blood) can help heal chronic bowel damage caused by radiation therapy. It is for people whose bowel symptoms, like diarrhea or pain, continue despite standard treatment.
This study looks at how your genetic makeup and response to radiation might help predict how well you will respond to chemotherapy and radiation therapy given before surgery for locally advanced rectal cancer. It may help doctors better personalize your treatment plan.
Hear when a new Radiation-induced Intestinal Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.